Skip to main content
KYONGBO PHARMACEUTICAL CO., LTD. logo

KYONGBO PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 214390 ISIN · KR7214390007 LEI · 988400YKOM1CHDS6R917 KO Manufacturing
Open in API
Filings indexed 206 across all filing types
Latest filing 2025-06-19 Director's Dealing
Country KR South Korea
Listing KO 214390

About KYONGBO PHARMACEUTICAL CO., LTD.

https://www.kbpharma.co.kr/en/home

Kyongbo Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering integrated services from early-stage development through to commercial cGMP production. Its core product portfolio includes a diverse range of APIs, such as sterile and non-sterile cephalosporins, carbapenem antibiotics, and high-potency cytotoxic anti-cancer agents. In addition to APIs, the company manufactures finished dosage forms, including solid oral medications and sterile injectables. Kyongbo Pharmaceutical utilizes dedicated and segregated manufacturing facilities to produce its specialized product lines, supported by a strong commitment to research and innovation in API synthesis.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Jung Hee Rok) of Kyongbo Pharmaceutical. This type of filing, which details personal share transactions by company insiders, is classified as a Director's Dealing report.
2025-06-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kim Jong Bin) of Kyobo Pharmaceutical. This type of filing, which details personal share transactions (insider trades) by company directors or executives, is classified as a Director's Dealing report.
2025-06-19 Korean
[기재정정]주요사항보고서(영업정지)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding a suspension of business operations (영업정지) due to a regulatory administrative action (product license cancellation). It details the legal proceedings, the court's stay of execution, and the company's response. Since this is a specific regulatory disclosure regarding a material event (legal/regulatory action) and does not fit into the other specific categories like M&A or financial reports, it is classified as a Regulatory Filing (RNS).
2025-06-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kim Do Kyoung) of Kyongbo Pharmaceutical. This type of filing, which details personal share transactions (insider trades) by company directors or executives, is classified as a Director's Dealing report.
2025-06-17 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report on Changes in Shareholding by Major Shareholders and Related Parties) filed by Kyungbo Pharmaceutical. It details specific share transactions (purchases) by company executives (e.g., Kim Do-kyung) and provides a comprehensive table of share ownership for major shareholders and related parties. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions by company insiders and updates the ownership status of major shareholders.
2025-06-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (specifically Chong Kun Dang Holdings and related individuals). This document type is used to report significant changes in shareholding percentages and is classified as a Major Shareholding Notification.
2025-06-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.